Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers January 20, 2018
Pharmacy Choice - News - U.S. Pharmaceutical Industry - January 20, 2018

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

1/20/18 - 3rd Annual Clinical Trial Collaborations Event Comes to Boston in April 2018 [Tehran Times (Iran)]
-The Conference Forum is pleased to announce the launch of the 3rd annual Clinical Trial Collaborations conference in Boston on April 9-11, 2018. Industry veteran, Dr Jeremy Chadwick, Group VP, Clinical Development Operations, Shire Pharmaceuticals, and conference chair, Dr Murray Abramson address in a fireside chat what it takes to develop strateg
1/20/18 - Avera To Enroll First Patients in Landmark Lung Cancer Tri-Therapy Clinical Trial [Sudan Tribune]
This clinical trial that received the approval of the FDA is Averas latest collaboration as part its membership in the Worldwide Innovative Networking Consortium. This latest step in our collaboration with WIN represents one clinical trial but is part of our larger goal to revolutionize cancer care through personalized medicine, said Benjamin Solom
1/20/18 - Clinical Trial Management Systems Market: Future Market Projections for Forthcoming Years
Albany, NY 01/19/2018 Lately, the global pediatric vaccination market has been exhibiting a robust growth. Various upcoming child healthcare programs by UNICEF and the WHO are likely to boost this market in the near future. North America, Europe, Asia Pacific, and the Rest of the World are the key regional markets for pediatric vaccines in th
1/20/18 - Combination of Encorafenib, Binimetinib and Cetuximab Demonstrated an 8 Month Median Progression-Free Survival in BRAF-Mutant Colorectal Cancer in Updated Safety Lead-In Results from BEACON Phase 3 Trial
BOULDER, Colo. and CASTRES, France, Jan. 20, 2018/ PRNewswire/ Array BioPharma Inc. and Pierre Fabre today announced updated results from the 30 patient safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab, an anti-EGFR antibody, in patients
1/20/18 - District Court Awards $5 Million in Civil Penalties and Enters Permanent Injunction to Prevent Dr. Reddys Laboratories Inc. from Distributing Prescription Drugs Not in Child-Resistant Packaging [AlArabiya.net (United Arab Emirates)]
The Department of Justice announced today that a federal court in New Jersey imposed a $5 million civil penalty and entered a consent decree of permanent injunction against Dr. Reddys Laboratories Inc. Dr. Reddys is the North American subsidiary of Dr. Reddys Laboratories Limited, a pharmaceutical company headquartered in India. The case involves..
1/20/18 - Dong-A ST stock surges upon export deal announcement [Arab Finance (Egypt)]
The share price of Dong-A ST, a pharmaceutical company, has been surging after the company announced its deal to transfer technology of DA-9801, a diabetic neuropathy treatment, to NeuroBo Pharmaceuticals, Thursday. Under the agreement, Dong-A ST will receive $2 million and a 5 percent stake in NeuroBo, with milestones of up to $178 million, follow
1/20/18 - Dry Powder Inhalers Market Trends & Opportunities with Forecast Up to
Albany, NY 01/19/2018 Dry powder inhalers are used to deliver drugs in dry powdered form to the lungs of patients suffering from respiratory disorders. Pulmonary drug delivery has been gaining attention and acceptance in the past few years in the treatment of respiratory disorders due to advantages such as faster drug absorption, high bioavai
1/20/18 - Ducey wants limits on doctor prescriptions
Doug Ducey wants lawmakers to enact a grab-bag of laws and authorize new regulations- many on doctors- in a bid to curb opioid abuse and overdoses. Legislation being crafted for a special legislative session this coming week includes:. Christina Corieri, the governor's health adviser, said the package was crafted with input from various interests,
1/20/18 - Ebola Treatment Market Research Report - Forecast 2016 - 2024: Ebola Treatment Market- Industry Value Forecast, Dynamics, growth, potential, segments, market share, Size, online PDF Report, Free Sample Copy, Future projection, Analysis, supply and de
New York, NY 01/19/2018 Ebola viral infection was first observed in The Democratic Republic of Congo in 1976. Ebola is a viral disease which frequently causes lethal haemorrhagic fever in humans. Top drug companies such as Hemispherx Biopharma, Biochryst Pharmaceuticals, Nano Vircides, Serepata Therapeutics, NewLink Genetics and Mapp Biopharm
1/20/18 - Exelixis Announces Presentation of Updated Phase 1b Results for the Combination of Cobimetinib and Atezolizumab in Metastatic Colorectal Cancer at the 2018 American Society of Clinical Oncology Gastrointestinal Cancers Symposium
Exelixis, Inc. today announced the presentation of updated results from the Genentech- sponsored phase 1 b clinical trial of cobimetinib, an Exelixis- discovered MEK inhibitor, in combination with atezolizumab, an anti-PDL1 antibody discovered and developed by Genentech, a member of the Roche Group, in patients with metastatic colorectal cancer.
1/20/18 - Genus Lifesciences Assigned Patent for Pharmaceutical Compositions
Genus Lifesciences, Allentown, Pennsylvania, has been assigned a patent developed by two co-inventors for "pharmaceutical compositions and methods of using the same." The co-inventors are Jeffrey M. Moshal, Allentown, Pennsylvania, and Michael Libman, Allentown, Pennsylvania. Written by Diptimayee Mishra; edited by Sudarshan Harpal.
1/20/18 - Not-for-profit hospitals coming up with their own generic medicines to combat shortages [Sudan Tribune]
Many of the major not-for-profit hospital groups have tried their hand an manufacturing and making generics to combat the shortages of medicines as well as the high costs of branded medications. This move bypasses the monopoly held by the pharmaceutical companies. Hospital groups that are joining hands in this venture include Intermountain Health,.
1/20/18 - P.F. Laboratories, Purdue Pharma, Purdue Pharmaceuticals Assigned Patent for Pharmaceutical Formulation Containing Gelling Agent
P.F. Laboratories, Totowa, New Jersey, Purdue Pharma, Stamford, Connecticut, and Purdue Pharmaceuticals, Wilson, North Carolina, have been assigned a patent developed by three co-inventors for a "pharmaceutical formulation containing gelling agent." The co-inventors are Curtis Wright, Rockport, Massachusetts, Benjamin Oshlack, Boca Raton, Florida,
1/20/18 - Pandion Therapeutics Closes $58 Million Series A Round [Syrian Arab News Agency]
The company announced the closing of its $58 million Series A round of financing, co-led by Polaris Partners, the founding investor that provided the initial seed funding, Versant Ventures and Roche Venture Fund. The company, based in North Cambridge, Massachusetts, also announced key leadership appointments including CEO Anthony J. Coyle, PhD, and
1/20/18 - Pharmaceutical Outsourcing Market Research Report - Forecast 2016 - 2024: Pharmaceutical Outsourcing Market- Industry Value Forecast, Dynamics, growth, potential, segments, market share, Size, online PDF Report, Free Sample Copy, Future projection, A
New York, NY 01/19/2018 Pharmaceutical outsourcing, principally for contract research organization and contract manufacturing organizations, has developed during past ten years, and signs are that it will continue to develop over the forecast period. Complete new outsourcing industry sectors, like high-throughput screening services, have beco
1/20/18 - Regen Biopharma Inc. Files SEC Form NT 10-K, Notification of Inability To Timely File Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, Or 10-KT405:...
Regen Biopharma Inc. Files SEC Form NT 10- K, Notification of Inability To Timely File Form 10- K 405, 10- K, 10- KSB 405, 10- KSB, 10- KT, Or 10- KT405:. By a News Reporter-Staff News Editor at Journal of Transportation According to news reporting originating from Washington, D.C., by VerticalNews journalists, a U.S. Securities and Exchange Comm
1/20/18 - Remsima push Celltrions net profit up 82.1% in 2017 [Syrian Arab News Agency]
Celltrion, a Korean biopharmaceutical firm, said Friday that its net profits soared 82.1 percent in 2017 from a year earlier on robust sales of its biosimilar drug Remsima overseas. Celltrion said its operating profit more than doubled to 517 billion won in 2017 from 253 billion won a year earlier. Celltrion also began selling another biosimilar dr
1/20/18 - Report Advocates for Employment of Community College Students in BioPharma Roles
Bunker Hill Community College graduate and Pfizer employee Ana Maria Ovalle spoke with WGBH News' Kirk Carapezza about the issue. After completing an internship at a biopharma company in Cambridge, Ovalle landed a job at Pfizer where she works in a bio-chemical lab full-time. Companies like Pfizer traditionally hired associate degree recipients to
1/20/18 - SOHM, Inc., Executes Non-Toxic Funding Commitment with Institutional Investor for Expansion of Core Business to Adopt Blockchain Technologies [Gulf Daily News (Bahrain)]
-SOHM, Inc. a globally-known generic pharmaceutical manufacturer, announces today that it has signed a binding Letter of Intent with a Canadian Institutional Investor for a sizable investment in SOHM. Management is confident that by incorporating blockchain technologies with its core business, SOHM will create a competitive advantage in the field o
1/20/18 - Study Results from City University of New York Broaden Understanding of Wellness [Limited output transcranial electrical stimulation (LOTES-2017):...
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week Current study results on Wellness have been published. According to news reporting originating in New York City, New York, by NewsRx journalists, research stated, "We present device standards for low-power non-invasive electrical brain stimulation devices classified as limite
1/20/18 - Survey of Ulcerative Colitis Patients and Gastroenterologists Indicates That Symptoms May Create a New Reality for Patients
Pfizer, a pharmaceutical company, issued the following news release:. Pfizer announced today findings from the U.S. UC Narrative survey1, 2 of ulcerative colitis patients and gastroenterologists. The U.S. survey findings are an initial analysis of a subset of the UC Narrative global survey, which was developed with input from the Global UC Narrativ
1/20/18 - Walgreens Boots Alliance Reports Fiscal 2018 First Quarter Results
By a News Reporter-Staff News Editor at Investment Weekly News Walgreens Boots Alliance, Inc. announced financial results for the first quarter of fiscal 2018 which ended 30 November 2017. Overview of First Quarter Results Fiscal 2018 first quarter net earnings attributable to Walgreens Boots Alliance determined in accordance with GAAP decreased
1/20/18 - Web Based E-Detailing Market Global Industry Analysis, Size, Share and Forecast 2016-2026: Future Market Insights has announced the addition of the Web Based e-Detailing Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report
Valley Cottage, NY 01/19/2018 Web based E-detailing is an interacting media platform wherein the pharmaceutical companies display their products sales presentation and brochures. Web based E-detailing allows the doctor or physician to look up to the medicines as per their requirement. The web based E-detailing is comparatively cost effective
1/20/18 - Zealand Pharma announces progress to Phase 3 with dasiglucagon for the treatment of congenital hyperinsulinism in first half 2018 [Tehran Times (Iran)]
Zealand receives FDA approval of its Investigational New Drug application for its Phase 3 program with dasiglucagon for treatment of congenital hyperinsulinism. Two Phase 3 trials are set to start within the coming months at leading centers in the U.S. and Europe. U.S. FDA and the European Commission have already granted orphan drug designation for
1/19/18 - "Combined Herbal and Pharmaceutical Composition and Method" in Patent Application Approval Process (USPTO 20170368124)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventor Syed, Uwais M., filed on June 27, 2016, was made available online on January 4, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a company or institution. The followi
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415